What is China-Gel?
China-Gel LLC operates as a specialized manufacturer of professional-grade topical pain relief solutions, integrating ancient herbal wisdom with modern therapeutic requirements. The company's product portfolio, which includes the signature Aulief cream, Aulief Gold organic formulations, and specialized Therapy Creme for sports rehabilitation, serves a dual-channel market of individual consumers and clinical health professionals. By focusing on natural, effective relief for conditions such as arthritis, backache, and joint inflammation, China-Gel has established a defensible niche in the competitive wellness landscape, prioritizing efficacy and practitioner-grade quality standards.
How much funding has China-Gel raised?
China-Gel has raised a total of $55K across 1 funding round:
Debt
$55K
Debt (2021): $55K with participation from PPP
Key Investors in China-Gel
PPP
Public-Private Partnership
What's next for China-Gel?
With the infusion of this latest capital, China-Gel is poised to accelerate its strategic growth initiatives, likely focusing on supply chain optimization and expanded distribution channels. As the company transitions through its current Series B/C stage, the focus will shift toward scaling production capacity to meet rising demand for natural pain management alternatives. Future milestones will likely involve enhancing digital direct-to-consumer engagement while maintaining the high-trust relationships with physical therapy and sports medicine practitioners that have defined the brand's longevity. The firm's ability to maintain its herbal integrity while scaling will be the primary determinant of its long-term market dominance.
See full China-Gel company page
